U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 2) by Azuma Hazuki on Wednesday January 23 2019, @11:26PM (1 child)
Nearly all of it? Just about the entire EU and the Scandinavian nations in particular do this the right way.
I am "that girl" your mother warned you about...
(Score: 2) by PartTimeZombie on Thursday January 24 2019, @01:30AM
Instead of "European" you could say OECD or "developed world" perhaps.
Those of us who live in Oceania have proper healthcare too. In fact, when I was in Australia on business once I though I was having a heart attack. I could not have had better care anywhere, and there was no charge, because why would there be?
My boss enquired if the company's insurance should get in touch with St. Vincent's Hospital in Melbourne and was told no, they don't have a collections department, so they would be no-one to give the money to anyway.